Form 4: EDCO Partners LLLP Acquires 210,000 Shares of Lifeloc Technologies, Inc.

Sentiment:

SEC Form 4 Filing


EDCO Partners LLLP, a 10% owner and director of Lifeloc Technologies, Inc., purchased 210,000 shares of common stock at $3.80 per share on July 23, 2024.

Summary

  • On July 23, 2024, EDCO Partners LLLP acquired 210,000 shares of Lifeloc Technologies, Inc. common stock.
  • The purchase price was $3.80 per share.
  • Following the transaction, EDCO Partners LLLP beneficially owns 2,065,319 shares of Lifeloc Technologies, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard transaction report, indicating a purchase by a significant shareholder, which could be interpreted as a positive signal, but without further context, it's difficult to gauge the overall impact.

Industry Context

This transaction reflects the investment activity of a major shareholder in Lifeloc Technologies, Inc., which could signal confidence in the company's future prospects. Monitoring similar filings from other companies in the alcohol detection and breathalyzer industry can provide insights into overall market sentiment and investment trends.

Stakeholder Impact

  • The increased ownership by EDCO Partners LLLP could be viewed positively by shareholders, potentially increasing investor confidence.

Key Dates

DateDescription
07/23/2024Date of transaction: EDCO Partners LLLP purchased 210,000 shares of LCLC.
07/25/2024Date of signature on the Form 4 filing.

Keywords

EDCO Partners LLLP, Lifeloc Technologies, LCLC, share acquisition, beneficial ownership, Form 4, SEC filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.